Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MIBC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07663747
What this trial is testing

Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC

Who this might be right for
Urothelial Bladder Cancer
The Netherlands Cancer Institute 56
Not applicableActive Not RecruitingNCT04167631
What this trial is testing

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Who this might be right for
MRI Contrast Media Adverse ReactionBladder CancerBladder Disease+4 more
Mansoura University 150
Very early researchWithdrawnNCT05395260
What this trial is testing

FL- 101 Study in Non-Metastatic MIBC

Who this might be right for
Muscle Invasive Bladder Carcinoma
Flame Biosciences
Testing effectiveness (Phase 2)Looking for participantsNCT06511648
What this trial is testing

Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations

Who this might be right for
Muscle-invasive Bladder Cancer
Spanish Oncology Genito-Urinary Group 90
Testing effectiveness (Phase 2)UnknownNCT03993249
What this trial is testing

Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy

Who this might be right for
Bladder Cancer
Hellenic GenitoUrinary Cancer Group 78
Large-scale testing (Phase 3)Active Not RecruitingNCT03924895
What this trial is testing

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

Who this might be right for
Urinary Bladder Cancer, Muscle-invasive
Merck Sharp & Dohme LLC 595
Large-scale testing (Phase 3)Looking for participantsNCT07693959
What this trial is testing

Neoadjuvant RC48 Plus Gemcitabine in HER2-Expressing MIBC

Who this might be right for
MIBC
Zhiquan Hu 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT05316155
What this trial is testing

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC 235
Not applicableNot Yet RecruitingNCT07744958
What this trial is testing

RESTORE-BLADDER (REgistry on STrategies for Organ pREservation in Muscle-invasive BLADDER Cancer)

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Heinrich-Heine University, Duesseldorf 100
Not applicableNot Yet RecruitingNCT07735793
What this trial is testing

Radical Cystectomy in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) and Muscle Invasive Bladder Cancer (MIBC) in Korea

Who this might be right for
Urinary Bladder Neoplasms
Janssen Korea, Ltd., Korea 1
Testing effectiveness (Phase 2)Study completedNCT03636256
What this trial is testing

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaUrinary Bladder Neoplasm+6 more
NanOlogy, LLC 36
Early research (Phase 1)Looking for participantsNCT05833867
What this trial is testing

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

Who this might be right for
Localized Muscle Invasive Bladder Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma
Shilpa Gupta, MD 20
Testing effectiveness (Phase 2)Ended earlyNCT04047693
What this trial is testing

Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma

Who this might be right for
Muscle Invasive Bladder CancerUrothelial CarcinomaNeoadjuvant Chemotherapy
Pusan National University Yangsan Hospital 24
Not applicableNot Yet RecruitingNCT07026864
What this trial is testing

MRI-Guided Bladder Preservation Program For Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Clinica Universidad de Navarra, Universidad de Navarra 31
Testing effectiveness (Phase 2)Ended earlyNCT02389764
What this trial is testing

Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT07296705
What this trial is testing

Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital 25
Not applicableStudy completedNCT06337591
What this trial is testing

Diagnostic Performance of the Vesical Imaging-Reporting and Data System (VI-RADS) in Detecting Muscle-invasive Bladder Tumour (MIBC) in Clinical Practice: Comparison With Transurethral Resection of Bladder Cancer (TURB) and Evaluation of Diagnostic Accuracy According to Tumour Location

Who this might be right for
Bladder Cancer
Istituto Nazionale di Ricovero e Cura per Anziani 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04700124
What this trial is testing

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 808
Not applicableLooking for participantsNCT07202845
What this trial is testing

Early Prediction of Neoadjuvant Chemotherapy Response in Bladder Cancer Using Quantitative Multiparametric MRI

Who this might be right for
MIBCmpMRINAC
Assiut University 39
Testing effectiveness (Phase 2)Study completedNCT01556243
What this trial is testing

Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 270
Next Page